Acta Pharmaceutica Sinica B

期刊基本信息

  • 期刊名称:Acta Pharmaceutica Sinica B
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ)
  • 期刊ISSN:2211-3835
  • 期刊EISSN:2211-3843
  • 简称:ACTA PHARM SIN B
  • 影响因子:14.6
  • 实时影响因子:截止2025年5月19日:14.47
  • 五年影响因子:15.2
  • JCI期刊引文指标:3.43
  • h-index:28
  • 2024-2025自引率:5.50%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/apsb/default.aspx
  • 是否OA开放访问:Yes
  • 出版商:Elsevier BV
  • 出版年份:2011

Acta Pharmaceutica Sinica B

Science Citation Index Expanded (SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)

期刊介绍

The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association
Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association

Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.

期刊语言要求

Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

投稿要求

  • 通讯方式:INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 10005
  • 涉及的研究方向:Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
  • 出版国家或地区:CHINA MAINLAND
  • 出版语言:English
  • 年文章数:308
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D

CITESCORE

CiteScoreSJRSNIPCiteScore排名
24.303.4892.465
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:General Pharmacology, Toxicology and Pharmaceutics
Q11 / 77
99%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ16/352
98.4%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ13/353
99.29%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
PHARMACOLOGY & PHARMACY
药学
2区4区1区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 3区1区2区
PHARMACOLOGY & PHARMACY
药学
2区4区1区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友